Genetics in neuroendocrine immunology: Implications for rheumatoid arthritis and osteoarthritis: Annals of the New York Academy of Sciences

Annals of the New York Academy of Sciences

Volumn 1193, Issue , 2010, Pages 10-14

  Stark, Klaus ^a   Straub, Rainer H ^a   Blažičková, Stanislava ^b   Hengstenberg, Christian ^a   Rovenský, Jozef ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

Candidate genes; Genome wide association studies; Neuroendocrine immunology; Osteoarthritis; Plexin A2; Polymorphisms; Rheumatoid arthritis

Indexed keywords

ADAM PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CD40 ANTIGEN; CYCLIN DEPENDENT KINASE 6; CYTOSOLIC PHOSPHOLIPASE A2; CYTOSOLIC PHOSPHOLIPASE A2 GROUP IVA; HERPESVIRUS ENTRY MEDIATOR; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR BETA; IODOTHYRONINE; KINESIN; KINESIN FAMILY MEMBER 5A; MEMBRANE METALLOENDOPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE LIKE 1; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PHOSPHATIDYLINOSITOL 5 PHOSPHATE 4 KINASE TYPE II GAMMA; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2; PROSTAGLANDIN SYNTHASE; PROTEIN ADAM12; PROTEIN KINASE C THETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; STAT4 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; CONFERENCE PAPER; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETICS; GENOME ANALYSIS; HEREDITY; HUMAN; HYPOTHESIS; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINOLOGY; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77951237955     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05288.x     Document Type: Conference Paper

References (39)

1. Stastny, P. 1978. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med. 298: 869-871.
2. Bowes, J. & A. Barton. 2008. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 47: 399-402.
3. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven commondiseases and 3,000 shared controls.Nature 447: 661-678.
4. Remmers, E.F., R.M. Plenge, A.T. Lee, et al. 2007. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.N. Engl. J. Med. 357: 977-986.
5. Plenge, R.M., C. Cotsapas, L. Davies, et al. 2007. Two independent alleles at 6q23 associatedwith risk of rheumatoid arthritis. Nat. Genet. 39: 1477-1482.
6. Thomson, W., A. Barton, X. Ke, et al. 2007. Rheumatoid arthritis association at 6q23. Nat. Genet. 39: 1431-1433.
7. Plenge, R.M., M. Seielstad, L. Padyukov, et al. 2007. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N. Engl. J. Med. 357: 1199-1209.
8. Kurreeman, F.A., L. Padyukov, R.B.Marques, et al. 2007. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS.Med. 4: e278-e278
9. Han, S.W.,W.K. Lee, K.T. Kwon, et al. 2009. Association of polymorphisms in interferon regulatory factor 5 gene with rheumatoid arthritis: a metaanalysis. J. Rheumatol. 36: 693-697.
10. Raychaudhuri, S., E.F. Remmers, A.T. Lee, et al. 2008. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet. 40: 1216-1223.
11. Barton, A.,W. Thomson, X. Ke, et al. 2008. Rheumatoid arthritis susceptibility loci at chromosomes10p15, 12q13 and 22q13. Nat. Genet. 40: 1156-1159.
12. Valdes, A.M., J. Loughlin, K.M. Timms, et al. 2008. Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am. J. Hum. Genet. 82: 1231-1240.
13. Miyamoto, Y.,D. Shi, M.Nakajima, et al. 2008.Common variants in DVWA on chromosome 3p24.3 are associated with susceptibility to knee osteoarthritis. Nat. Genet. 40: 994-998.
14. Meulenbelt, I., K. Chapman, R. Eguez-Gonzalez, et al. 2009. Large replication study and meta-analyses of DVWA as an osteoarthritis susceptibility locus in European and Asian populations. Hum. Mol. Genet. 18: 1518-1523.
15. Bos, S.D., P.E. Slagboom & I. Meulenbelt. 2008. New insights into osteoarthritis: early developmental features of an ageing-related disease. Curr. Opin. Rheumatol. 20: 553-559.
16. Mahr, S., G.R. Burmester, D. Hilke, et al. 2006. Cisand trans-acting gene regulation is associated with osteoarthritis. Am. J. Hum. Genet. 78: 793-803.
17. Meulenbelt, I., J.L.Min, S. Bos, et al. 2008. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum. Mol. Genet. 17: 1867-1875.
18. Mototani, H., A. Iida, M. Nakajima, et al. 2008. A functional SNP in EDG2 increases susceptibility to knee osteoarthritis in Japanese. Hum. Mol. Genet. 17: 1790-1797.
19. Spector, T.D., R.H. Reneland, S. Mah, et al. 2006. Association between a variation in LRCH1 and knee osteoarthritis: a genome-wide single-nucleotide polymorphism association study using DNA pooling. Arthritis Rheum. 54: 524-532.
20. Valdes, A.M., O.M. Van, D.J. Hart, et al. 2006. Reproducible genetic associations between candidate genes and clinical knee osteoarthritis in men and women. Arthritis Rheum. 54: 533-539.
21. Valdes, A.M., J. Loughlin,M.V.Oene, et al. 2007. Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee. Arthritis Rheum. 56: 137-146.
22. Ikegawa, S. 2007.Newgene associations in osteoarthritis: what do they provide, and where are we going? Curr. Opin. Rheumatol. 19: 429-434.
23. Chapman, K., A. Takahashi, I.Meulenbelt, et al. 2008. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5-UTR of GDF5 with osteoarthritis susceptibility. Hum. Mol. Genet. 17: 1497-1504.
24. Miyamoto, Y., A. Mabuchi, D. Shi, et al. 2007. A functional polymorphism in the 5-UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat. Genet. 39: 529-533.
25. Southam, L., J. Rodriguez-Lopez, J.M. Wilkins, et al. 2007. An SNP in the 5-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum. Mol. Genet. 16: 2226-2232.
26. Valdes, A.M., T.D. Spector, S. Doherty, et al. 2008. Association of the DVWA and GDF5 polymorphismswith osteoarthritis in UK populations. Ann. Rheum. Dis. [Epub ahead of print].
27. Altman, R., E. Asch, D. Bloch, et al. 1986. Development of criteria for the classification and reporting of osteoarthritis.Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American RheumatismAssociation.ArthritisRheum. 29: 1039-1049.
28. Altman, R., G. Alarcon, D. Appelrouth, et al. 1990. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 33: 1601-1610.
29. Altman, R., G. Alarcon, D. Appelrouth, et al. 1991. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 34: 505-514.
30. Arnett, F.C., S.M. Edworthy, D.A. Bloch, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
31. Martinez, A., J. Varade, J.R. Lamas, et al. 2008. GDF5 Polymorphism associated with osteoarthritis: risk for rheumatoid arthritis. Ann. Rheum. Dis. 67: 1352-1353.
32. Diarra, D., M. Stolina, K. Polzer, et al. 2007. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13: 156-163.
33. Cutolo, M., R.H. Straub & J.W. Bijlsma. 2007. Neuroendocrine-immune interactions in synovitis. Nat. Clin. Pract. Rheumatol. 3: 627-634.
34. Donn, R.P., A. Farhan, A. Stevans, et al. 2002. Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Rheumatology (Oxford) 41: 930-936.
35. Wagner, U., M. Wahle, F. Moritz, et al. 2006. Promoter polymorphisms regulating corticotrophinreleasing hormone transcription in vitro. Horm. Metab Res. 38: 69-75.
36. Wagner, U., M. Wahle, O. Malysheva, et al. 2006. Sequence variants of the CRH 5-flanking region: effects on DNA-protein interactions studied by EMSA in PC12 cells. Ann. N. Y. Acad. Sci. 1069: 20-33.
37. Baerwald, C.G., G.S. Panayi&J.S. Lanchbury. 1997. Corticotropin releasing hormone promoter region polymorphisms in rheumatoid arthritis. J. Rheumatol. 24: 215-216.
38. Julia, A, D. Gallardo, F. Vidal, et al. 2003. Association study between corticotrophin-releasing hormone genomic region (8q13) and rheumatoid arthritis in the Spanish population. Rheumatology (Oxford) 42: 1534-1538.
39. Miller, L.E., C. Weidler, W. Falk, et al. 2004. Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 50: 1156-1163.